Does weight impact efficacy of ‘morning after pill’?

The TGA says it will continue to review the impact of weight on emergency contraceptives, as the European Medicines Agency revealed it was assessing potential labelling changes for the products.

The move to review emergency contraceptives labels follows research, published in November by French pharmaceutical company, HRA Pharma, that indicated its ‘morning after pill’, NorLevo (levonorgestrel)